EQL Pharma AB (publ) announced Christer Fåhraeus, Founder & CEO, notified the board in the autumn of 2021 that he intends to transition into a board position after the Annual General Meeting (AGM) in August 2022. At that time, the board appointed Axel Schörling, Deputy CEO, as new CEO after Fåhraeus' resignation following the AGM in August 2022. After AGM, Schörling has assumed the position as new CEO in EQL.

In connection with this, Martin Kristofferson, previously Director Strategic Sourcing, has been appointed new COO.